Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy

International Journal of Experimental Pathology

Volumn 92, Issue 1, 2011, Pages 57-65

  Au, Carol G ^a,b   Butler, Tanya L ^a,b   Sherwood, Megan C ^a   Egan, Jonathan R ^a,b   North, Kathryn N ^a,b   Winlaw, David S ^a,b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b University of Sydney   (Australia)

Author keywords

Cardiac fibrosis; Cardiomyopathy; Connective tissue growth factor; Duchenne muscular dystrophy

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE A; GELATINASE B; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHIC CARDIOMYOPATHY; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; BLOTTING, WESTERN; CARDIOMYOPATHIES; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE MODELS, ANIMAL; FIBROSIS; MALE; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79251575578     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2010.00750.x     Document Type: Article

References (48)

1. Abreu J.G., Ketpura N.I., Reversade B., De Robertis E.M. (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat. Cell Biol. 4, 599-604.
2. Bauer R., Straub V., Blain A., Bushby K., MacGowan G.A. (2009) Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy. Eur. J. Heart Fail. 11, 463-471.
3. Bia B.L., Cassidy P.J., Young M.E. et al. (1999) Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. J. Mol. Cell. Cardiol. 31, 1857-1862.
4. Bostick B., Yue Y., Long C., Duan D. (2008) Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression. Circ. Res. 102, 121-130.
5. Bushby K., Muntoni F., Bourke J.P. (2003) 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul. Disord. 13, 166-172.
6. Butler T.L., Au C.G., Yang B. et al. (2006) Cardiac aquaporin expression in humans, rats, and mice. Am. J. Physiol. Heart Circ. Physiol. 291, H705-H713.
7. Candido R., Forbes J.M., Thomas M.C. et al. (2003) A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ. Res. 92, 785-792.
8. Chamberlain J.S., Metzger J., Reyes M., Townsend D., Faulkner J.A. (2007) Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J. 21, 2195-2204.
9. Chen M.M., Lam A., Abraham J.A., Schreiner G.F., Joly A.H. (2000) CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J. Mol. Cell. Cardiol. 32, 1805-1819.
10. Cohn R.D., van Erp C., Habashi J.P. et al. (2007) Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13, 204-210.
11. Creemers E.E., Davis J.N., Parkhurst A.M. et al. (2003) Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am. J. Physiol. Heart Circ. Physiol. 284, H364-H371.
12. Danialou G., Comtois A.S., Dudley R. et al. (2001) Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J. 15, 1655-1657.
13. Dean R.G., Balding L.C., Candido R. et al. (2005) Connective tissue growth factor and cardiac fibrosis after myocardial infarction. J. Histochem. Cytochem. 53, 1245-1256.
14. Deschamps A.M., Spinale F.G. (2006) Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovasc. Res. 69, 666-676.
15. Fedak P.W., Verma S., Weisel R.D., Li R.K. (2005) Cardiac remodeling and failure From molecules to man (Part II). Cardiovasc. Pathol. 14, 49-60.
16. Frazier K., Williams S., Kothapalli D., Klapper H., Grotendorst G.R. (1996) Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J. Invest. Dermatol. 107, 404-411.
17. Grotendorst G.R., Okochi H., Hayashi N. (1996) A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 7, 469-480.
18. Guha M., Xu Z.G., Tung D., Lanting L., Natarajan R. (2007) Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J. 21, 3355-3368.
19. Heymans S., Lupu F., Terclavers S. et al. (2005) Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. Am. J. Pathol. 166, 15-25.
20. Hoffman E.P., Brown R.H. Jr, Kunkel L.M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928.
21. Huebner K.D., Jassal D.S., Halevy O., Pines M., Anderson J.E. (2008) Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone. Am. J. Physiol. Heart Circ. Physiol. 294, H1550-H1561.
22. Jefferies J.L., Eidem B.W., Belmont J.W. et al. (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112, 2799-2804.
23. Kamogawa Y., Biro S., Maeda M. et al. (2001) Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo. Cardiovasc. Res. 50, 509-515.
24. Khairallah M., Khairallah R., Young M.E. et al. (2007) Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. J. Mol. Cell. Cardiol. 43, 119-129.
25. Koitabashi N., Arai M., Kogure S. et al. (2007) Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 49, 1120-1127.
26. Lang C., Sauter M., Szalay G. et al. (2008) Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis. J. Mol. Med. 86, 49-60.
27. Li G., Xie Q., Shi Y. et al. (2006) Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J. Gene Med. 8, 889-900.
28. Matsusaka H., Ide T., Matsushima S. et al. (2006) Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload. Hypertension 47, 711-717.
29. McLennan S.V., Wang X.Y., Moreno V., Yue D.K., Twigg S.M. (2004) Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy. Endocrinology 145, 5646-5655.
30. Miner E.C., Miller W.L. (2006) A look between the cardiomyocytes: the extracellular matrix in heart failure. Mayo Clin. Proc. 81, 71-76.
31. Moriuchi T., Kagawa N., Mukoyama M., Hizawa K. (1993) Autopsy analyses of the muscular dystrophies. Tokushima J. Exp. Med. 40, 83-93.
32. Morrison J., Lu Q.L., Pastoret C., Partridge T., Bou-Gharios G. (2000) T-cell-dependent fibrosis in the mdx dystrophic mouse. Lab. Invest. 80, 881-891.
33. Nigro G., Comi L.I., Politano L., Bain R.J. (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int. J. Cardiol. 26, 271-277.
34. Ohnishi H., Oka T., Kusachi S. et al. (1998) Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J. Mol. Cell. Cardiol. 30, 2411-2422.
35. Panek A.N., Posch M.G., Alenina N. et al. (2009) Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS ONE 4, e6743.
36. Quinlan J.G., Hahn H.S., Wong B.L. et al. (2004) Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul. Disord. 14, 491-496.
37. Shi-Wen X., Leask A., Abraham D. (2008) Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 19, 133-144.
38. Sicinski P., Geng Y., Ryder-Cook A.S. et al. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578-1580.
39. Sonnylal S., Shi-Wen X., Leoni P. et al. (2010) Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum. 62, 1523-1532.
40. Spurney C.F., Knoblach S., Pistilli E.E. et al. (2008) Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart. Neuromuscul. Disord. 18, 371-381.
41. Sun G., Haginoya K., Wu Y. et al. (2008) Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy. J. Neurol. Sci. 267, 48-56.
42. Turgeman T., Hagai Y., Huebner K. et al. (2008) Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone. Neuromuscul. Disord. 18, 857-868.
43. Wang W., Schulze C.J., Suarez-Pinzon W.L. et al. (2002) Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106, 1543-1549.
44. Wang X., McLennan S.V., Allen T.J., Twigg S.M. (2010) Regulation of pro-inflammatory and pro-fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytes. J. Cell Commun. Signal. 4, 15-23.
45. Way K.J., Isshiki K., Suzuma K. et al. (2002) Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes 51, 2709-2718.
46. Williams I.A., Allen D.G. (2006) Intracellular calcium handling in ventricular myocytes from mdx mice. Am. J. Physiol. Heart Circ. Physiol 292, H846-H855.
47. Williams I.A., Allen D.G. (2007) The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am. J. Physiol. Heart Circ. Physiol. 293, H1969-H1977.
48. Yasuda S., Townsend D., Michele D.E. et al. (2005) Dystrophic heart failure blocked by membrane sealant poloxamer. Nature 436, 1025-1029.